In 963 patients, participating in a randomized study of low molecular weight heparin in unstable coronary artery disease and followed for 5 months, troponin T was determined. In the 766 patients with a pre-discharge exercise test both troponin T level and exercise test response were independent predictors of prognosis. Cardiac death or myocardial infarction occurred in 5, 9 and 13% of the patients with a maximal troponin T level of <006 (n= 154), 0-06-0-2 (n= 175) and >0-2ug.l~' (n=437), respectively. Based on exercise tolerance and occurrence of ST depression, patients with a low (n = 361), intermediate (n = 325) and high risk (n = 80) exercise test response were identified. In these, death or myocardial infarction occurred in 5, 13 and 29%, respectively. The combination of troponin T and the exercise test response allowed an even better categorization into low (n = 84), intermediate (n=406) and high (n=276) risk groups with 1, 7 and 20% death or myocardial infarction, respectively. Among those 197 patients unable to perform an exercise test the incidence was 3, 16 and 27% in patients with troponin T <006, 006-0-2 and >0-2 ug . 1 ~ ', respectively. Thus, troponin T determinations and pre-discharge exercise tests alone and combined are valuable for risk assessment in unstable coronary artery disease.
Introduction
Unstable coronary artery disease, i.e. unstable angina or acute non-Q wave myocardial infarction, is an increasingly common reason for hospitalization [1) . It is, in most cases, possible to stabilize patients with unstable coronary artery disease during the first day with intense medical treatment' 11 . While in-hospital mortality is low, the incidence of cardiac events during the subsequent months is still high' 2 ' 31 . However, since the unstable coronary artery disease population is heterogeneous both regarding the severity of the underlying coronary artery disease and prognosis' 4 " 81 , early risk stratification is essential' 91 . Previous studies have demonstrated the safety and the prognostic value both of symptom-limited preRevision submitted 21 November 1995, and accepted 3 April 1996.
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Correspondence: Bertil Lindahl, Department of Cardiology, University Hospital, S-751 85 Uppsala, Sweden. discharge exercise tests' 10 ' 31 and of troponin T determinations' 14151 . However, no previous study has evaluated the simultaneous use of both these tests for prognostic purposes. Therefore, the aim of the present study was to evaluate, compare and combine the prognostic value of troponin T with a pre-discharge exercise test and other clinical findings in a large cohort of patients with unstable coronary artery disease.
Patients and methods

Patients
The study was part of a randomized trial of low molecular weight heparin (dalteparin sodium, Fragmin, Pharmacia AB, Sweden) in patients with unstable coronary artery disease including 1506 patients at 23 hospitals in Sweden between May 1992 and October 1994. The study cohort was recruited from 15 hospitals in which the protocol included a special blood sampling schedule.
Men or women over 40 years of age hospitalized because of myocardial ischaemia indicated both by symptoms and ECG changes were eligible for inclusion. The required symptoms were either new onset or increasing angina pectoris of 2 months' duration, with the last episode of chest pain within 72 h, or ongoing chest pain suggestive of myocardial infarction. In a 12-lead ECG at rest, the required signs of myocardial ischaemia were either ST depression of >0-l mV or T-wave inversion, or both in two contiguous leads. The exclusion criteria were: women before menopause, indication for thrombolysis (i.e. ST elevation or bundle branch block and start of chest pain within last 12 h), new Q wave, Q waves in the same leads as ST-depression or T-wave inversion, low bundle branch block, pacemaker, suspected myocarditis or pericarditis, septic endocarditis, cardiomyopathy, significant aortic valve disease, uncontrolled hypertension, hypotension, planned percutaneous transluminal coronary angioplasty or coronary artery bypass graft, increased risk of bleeding, anaemia, renal failure, hepatic failure, fever > 39° C, serious intercurrent disease, hypersensitivity to heparin or low molecular weight heparin and unwillingness or inability to participate.
After admission, all patients without contraindications received oral aspirin 75 mg o.d. and betablockers and, as needed, organic nitrates and calcium antagonists. Double-blind placebo-controlled randomized treatment fragmin/placebo was given as subcutaneous injections b.d. at a dose of 120 Units . k g " 1 body weight for the first 5-7 days and then o.d. at a dose of 7500 Units for another 5 weeks. Coronary angiography and revascularization was recommended in cases of refractory or incapacitating angina despite medical treatment or signs of severe ischaemia at an exercise test. All therapeutic decisions were made without knowledge of the patients' troponin T levels. The patients were followed by outpatient visits after 6 weeks and 5-6 months.
The present analysis concerned all patients who had at least one blood sample obtained for analysis of troponin T at inclusion and/or after 12 h (n = 976). In order to avoid confusion between the prognostic and diagnostic capacity of troponin T, all patients (n=13) with an event during the sampling period of 24 h and one day beyond were excluded. The study was approved by the local ethics committee and all enrolled patients provided informed consent.
Laboratory methods
Standard 12-lead ECGs were obtained at inclusion, after 24 h and at the time of the exercise test (days [5] [6] [7] [8] . ST depression was defined as a depression of the ST segment of > 0 1 mV below the isoelectric line in any lead measured 60 ms after the J-point. T-wave inversion was registered in cases of negative or isoelectric T-wave in leads V 2 -V 6 ,1 and II, in aVL if R>0-5 mV and in aVF if QRS was mostly positive.
A pre-discharge symptom-limited exercise test was performed in all patients with none of the following contraindications: myocardial infarction less than 4 days before the exercise test, appearance of new ECG changes in the last 2 days, ongoing chest pain, recurrent episodes of chest pain at rest or at slight effort, overt heart failure at the time of the exercise test, physical handicap or other conditions precluding an exercise test. The exercise test was performed with the patient sitting on an electrically braked bicycle ergometer starting at 10-30 W with a continuous load increase of lOW-min" 1 . The test was routinely terminated when limiting symptoms occurred, such as great exhaustion (Borg scale 17/20), moderately severe chest pain (5/10) or severe dyspnoea. For safety reasons, the test was also terminated in cases of ST depression >0-3mV, a fall in blood pressure >15mmHg measured once or >10mmHg measured twice within a 1 min interval, or severe arrhythmia. Heart rate was measured every minute. Systolic blood pressure was measured every 3rd min. Perceived exertion was rated by the patients every 3rd min using the Borg scale from 6-20 and chest pain every 3rd min during the test according to a 10° intensity scale' 16171 . A 12-lead ECG was continuously monitored before, during and up to 10 min after exercise. Computer-aided systems and thus, averaged ECG complexes were used for almost all exercise tests (Marquette Scandinavia, Sollentuna, Sweden; Schiller Switzerland, FMAB, Partille, Sweden; Siemens Elema AB, Stockholm, Sweden). The ST segment was measured 006 s after the J-point and related to the PQ segment. In cases of ST depression at rest, the changes were related to the ST level in the ECG immediately before the start of the test. All ECGs and exercise tests were interpreted centrally (Departments of Clinical Physiology, Uppsala and Jonkoping, respectively) and without knowledge of the patients' diagnosis and outcome.
Previous studies from our group have shown that a low maximal workload and/or the number of leads with ST depression are independent predictors of future cardiac events' 13181 and severity of coronary lesions'
191
, respectively. In accordance with the previous results 1 ' 3 ' 191 , a combination of these factors was used to define: 'high risk exercise test response'= low maximal workload in combination with ST depression of > 0 1 mV in >3 leads; 'intermediate risk exercise test response'=either a low maximal workload or ST depression of > 0 1 mV in >3 leads and 'low risk exercise test response'= neither low maximal workload nor STdepression of > 0 1 mV in > 3 leads. A low maximal workload was defined as a workload below the 33rd percentile of the distribution for men (90 W) and women (70 W), respectively, in the total patient material.
Venous blood samples for analyses of plasma troponin T were obtained at inclusion and then after 12 and 24 h. Blood was collected in tubes containing EDTA, centrifuged and plasma was frozen in aliquots and stored for subsequent analysis. Troponin T was determined by the Enzymun-Test system (BoehringerMannheim, Germany)' 201 . The lower detection limit is 004 ug. 1 ' according to the manufacturer and the upper reference level in healthy blood donors is 0-06 ug . 1~ I[2I] . All analyses were carried out at one laboratory (Department of Clinical Chemistry, Uppsala) and without knowledge of the patients' diagnosis and outcome. The between-day coefficient of variation over 4 months (n = 99) at our laboratory was 10-2 and 5 1 % at a level of 0-28 and 6-10 ug . 1 ~ ', respectively.
According to a previous report from the present study, the maximal troponin T level obtained during the first 24 h was an independent predictor of future cardiac events (cardiac death or myocardial infarction) in patients with unstable coronary artery disease' 22 ' and the addition of samples at 48 and 120 h, respectively, did not improve the prognostic value of troponin T. A maximal troponin T level during the first 24 h of <006, 006-0-2 and >0-2 ug . 1" ' separated the subjects into low, intermediate and high risk groups, respectively, and these cut-off values were used in the present analysis.
Evaluation of index event and end points
The episode that caused the enrolment in the study (index event) was retrospectively classified as acute myocardial infarction or unstable angina based on the maximal levels of available cardiac enzymes. The following biochemical markers have been obtained and analysed at the local hospital immediately following that episode: creatine kinase-MB (mass) determined by the IMx system (Abbot Laboratories, North Chicago, U.S.A.), discrimination limit 15 (ig. I" 1 (n = 614) or by the Icon-QSR system (Hybritech, San Diego, U.S.A.), discrimination limit l O u g . l " 1 (n=45); creatine kinase (catalytic activity), discrimination limit 2-5 ukat. 1 ~ ' for women and 30 for men (n=150); creatine kinase-MB (cat), discrimination limit 0-4 ukat. 1 ~ ' (n = 110) and aspartate aminotransferase, discrimination limit 0-6 ukat. 1 ~' for women and 08 ukat. 1 ~ ' for men (n=43). The three latter enzymes were analysed according to the IFCC/ECCLS standards' 231 .
All primary endpoints, i.e. death and non-fatal myocardial infarction were classified by an independent endpoint committee. Myocardial infarction was defined by conventional WHO criteria' 241 satisfying two out of the following three criteria: (1) severe ischaemic chest pain of at least 20 min duration, (2) a diagnostic ECG or (3) an increase in cardiac enzymes above the upper reference level in at least two consecutive samples at the local hospital. Causes of death were, whenever possible, based on autopsies. Sudden death was considered cardiac.
Statistical analysis
Differences in proportions were judged by chi-square. For non-parametric unrelated data, the Mann-Whitney test was used. The cumulative hazard curves were constructed using the Kaplan-Meier method. The endpoint was cardiac death or non-fatal myocardial infarction.
Non-cardiac death was treated as a censored observation. Statistical assessment was performed using the log-rank test. A significant difference was considered to exist at the P<005 level.
To identify variables of prognostic importance, simple and forward stepwise multiple logistic regression analyses were used regarding the pre-defined endpoints cardiac death or myocardial infarction. Evaluated independent variables were age (<70/>70 years), sex, smoking habits, history of hypertension, congestive heart failure, diabetes mellitus, previous myocardial infarction; inclusion diagnosis (myocardial infarction/ unstable angina), use of digoxin, ACE inhibitor and number of anti-anginal drugs (beta-blockade, CAinhibitor and long-acting organic nitrate) at the time of the exercise test, occurrence of Q wave, ST depression and T wave inversion in the 12-lead ECG at the time of the exercise test, serum-creatinine at admission, maximum troponin T during first 24 h (<006/0-06-0-2/ >0-2ug.l~') and exercise test response ('high risk'/ 'intermediate risk'/'low risk').
All statistical analyses were performed by a computer, utilising the SPSS system 6.1 (Statistical Package for the Social Sciences, 1994).
Results
General findings
An exercise test was performed in 766 (80%) patients constituting the exercise test group. The non-exercise test group was composed of the remaining 197 (20%) patients in whom an exercise test either was contraindicated (n = 181) or an event had occurred before the scheduled time of the test (n= 16) (Fig. 1) . Patients in the non-exercise test group compared to the exercise test group were older, more often females and had more severe cardiovascular disease, i.e. more previous myocardial infarction, stroke, heart failure and medication ( Table 1 ). The median troponin T maximum did not differ between the exercise test and non-exercise test group (0-30 vsO-45ug.P", P=0-ll).
During the 5 months' follow-up of the 766 patients in the exercise test group and of the 181 patients with contraindications to the exercise test in the nonexercise test group, 73 and 23 (10 and 13%, ns) patients, respectively, suffered a myocardial infarction and 22 and 13 (2-9 and 7-2%, / ) <001) patients, respectively, died a cardiac-related death. Coronary artery bypass graft or percutaneous transluminal coronary angioplasty was performed in 243 and 83 (32 and 42%, P<Q0\) patients of the exercise test and non-exercise test groups, respectively.
The non-exercise test group
Of the 197 patients in the non-exercise test group, 33, 44 and 120 patients had a maximal troponin T level <006, 006-0-2 and >0-2ug. I" 1 , respectively. The incidence of cardiac death or myocardial infarction were 1 (3%), Eur Heart J, Vol. 18, May 1997 (7) 43 (22) 131 (67) 156 (79) CHF=congestive heart failure. Values are median (25th-75th percentile) or n (%). = /><005, ** = P<00\ and *** = P<000\.
2 (4-5%) and 13 (11%) after 6 days (ns), respectively and 1 (3%), 7 (16%) and 32 (27%) after 5 months, respectively (pooled log rank, P-001).
The exercise test group Comparison of exercise test and troponin 71 An exercise test was performed a median of 5 days after inclusion
(range 3-9 days). The findings at the exercise test are summarized in Table 2 As patients' risk increased, particularly in relation to maximal troponin T and the exercise test response (Table 3) , there was a successive increase in the rates of cardiac death alone and the combined endpoint myocardial infarction or cardiac death, respectively, after 5 months. However, the rates of coronary artery bypass graft or percutaneous transluminal coronary angioplasty increased only in relation to the exercise test response category (Table 3) .
Comparison with other clinical variables
The prognostic value of troponin T, exercise test and other clinical and laboratory variables were compared in the exercise test group using the forward stepwise logistic multivariate regression analysis (Table 4) . Only the categories of exercise test response and maximal troponin T level were identified as variables of independent prognostic value for myocardial infarction or cardiac death at 5 months. Although significant in univariate analysis, variables such as sex, age, previous myocardial infarction, ECG findings at rest and serum creatinine did not add any independent information to exercise test response and troponin T level. The inclusion diagnosis was neither in the univariate nor in the multivariate analysis of predictive value.
Combination of troponin T and exercise test
The incidence of cardiac death or myocardial infarction after 5 months in subsets divided according to a combination of the exercise test response and the maximal troponin T level are shown in Fig. 2 . There was a wide distribution of risks for future cardiac events in the different subsets from a very low risk of 1% to a very high risk of 34%. The subset with 1% risk, as defined by Eur Heart J, Vol. 18, May 1997 Fig. 3 .
Discussion
Despite the high age of the study population, the pre-discharge exercise test could be performed in a large proportion of patients (80%). The patients were older and had more severe cardiovascular disease in the nonexercise test than in the exercise test group. Consequently, the incidence of cardiac events was somewhat higher in the non-exercise test group, in accordance with previous experience' 25 ' , previous studies. However, most previous studies were done before the widespread use of revascularization, which might be expected to decrease the prognostic value, as patients with strongly positive exercise tests are likely to be revascularized early. In the present study, the rate of revascularization was influenced by the exercise test response (Table 3) in accordance with the recommendations in the protocol. In spite of the higher rates of revascularization at more severe exercise test response, the prognostic value of the exercise test remained significant regarding cardiac death or myocardial infarction.
The cardiac isoform of troponin T is unique and can be differentiated from the isoforms in the skeletal muscle. It is virtually unmeasurable in plasma from healthy subjects-leading to a very high sensitivity and specificity for myocardial damage' 20 '. Previous studies, including a previous report from this study, have demonstrated that even minor elevations of troponin T in patients with acute ischaemic heart disease indicate an increased risk of future cardiac events' 14 ' 15 ' 221 . In the present study, troponin T determinations were prognostically useful both in the exercise test and non-exercise test group. Even in the clinically high-risk non-exercise test group, troponin T determinations could identify a How can the independent prognostic value of troponin T determinations and exercise tests be explained? A rupture of an atherosclerotic plaque leading to thrombus formation impeding the coronary blood flow is considered to be the major pathogenetic mechanism in unstable coronary artery disease' 3 ''. As no elevation of troponin T has been demonstrated in reversible ischaemia, even a minor elevation of troponin T probably indicates that there has been an, at least transient, thrombotic or embolic occlusion of a coronary artery, with interrupted flow long enough to cause myocardial damage. On the other hand, ischaemic ECG changes at the exercise test indicate a severe stenosis in the coronary vasculature, impeding the ability to match the raised oxygen demand with increased supply' 32 ', without necessarily implying a thrombotic condition. Furthermore, a low exercise tolerance together with ST depression during exercise increases the probability of multivessel disease' 191 and diastolic dysfunction' 33 '. Thus, the independent prognostic values of troponin T determinations and exercise tests might be a reflection of different pathophysiological mechanisms in unstable coronary artery disease. Thereby, the substantially increased risk in patients with both elevation of troponin T and a high risk exercise test response might be explained by an ongoing thrombotic condition in severely diseased coronary arteries.
Clinical implications
Determination of maximal troponin T level during the first 24 h is an inexpensive and simple method for early risk assessment in patients with unstable coronary artery disease. By adding a symptom-limited exercise test a few days after clinical stabilization, another safe, inexpensive and widely applicable method, the risk assessment can be further improved. The combination of troponin T and the exercise test response will allow the identification of low, intermediate and high risk categories. Patients in the low risk category have a very low risk for cardiac death or myocardial infarction during the subsequent months and further evaluation and invasive procedures seems unwarranted in the absence of incapacitating symptoms. In contrast, in the high risk category, the severe short-term prognosis warrants immediate consideration of revascularization. The intermediate category can often be handled with intense protective medication and continuous evaluation of the individual risk-benefit ratio of a revascularization procedure during follow-up.
